Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicity
Open Access
- 1 July 1998
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 78 (2) , 189-197
- https://doi.org/10.1038/bjc.1998.463
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Pretargeted tumour imaging with streptavidin immunoconjugates of monoclonal antibody CC49 and 111In-DTPA-biocytinNuclear Medicine and Biology, 1996
- Tumor pretargeting: almost the bottom line.1995
- Pharmacokinetics of [3H]Biotin Bound to Different Avidin AnaloguesJournal of Drug Targeting, 1995
- Antibody-guided scintigraphy: targeting of the ?magic bullet?European Journal of Nuclear Medicine and Molecular Imaging, 1993
- Enzyme modification by MPEG with an amino acid or peptide as spacer armsApplied Biochemistry and Biotechnology, 1991
- Studies on the biotin-binding sites of avidin and streptavidin. Tyrosine residues are involved in the binding siteBiochemical Journal, 1990
- Intraperitoneal radio‐localization of tumors pre‐targeted by biotinylated monoclonal antibodiesInternational Journal of Cancer, 1990
- The avidin-biotin complex in bioanalytical applicationsAnalytical Biochemistry, 1988
- REDUCTION IN IMMUNOGENICITY AND CLEARANCE RATE OF ESCHERICHIA-COLI L-ASPARAGINASE BY MODIFICATION WITH MONOMETHOXYPOLYETHYLENE GLYCOL1981
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970